Company: OCEA
Filing Date: 2025-01-13
Form Type: 10-Q
Source: 0001493152-25-001880
Chunk: 3

Company: Ocean Biomedical, Inc.
Filing Date: 2025-01-13
Form: 10-Q
Item: Item 1
Chunk 3
---
 Additional Paid-In  
    Accumulated  
    Total Stockholders’ 

    Shares  
    Amount  
    Capital  
    Deficit  
    Deficit 
  
    Balances at June 30, 2024 
     35,468,628  
        -  
    $107,547  
    $(200,290) 
    $    (92,743)
  
    Net income 

     (5,528) 
     (5,528)
  
    Stock-based compensation 
     -  
     -  
     186  
     -  
     186 
  
    Balances at September 30, 2024 
     35,468,628  
     -  
    $107,733  
    $(205,818) 
    $(98,085)

For
the Three Months Ended September 30, 2023

    Common  
    Additional Paid-In  
    Accumulated  
    Total Stockholders’ 

    Shares  
    Amount  
    Capital  
    Deficit  
    Deficit 
  
    Balances at June 30, 2023 
     34,012,724  
    $      -  
    $103,455  
    $(165,112) 
    $    (61,657)
  
    Net loss 
     -  
     -  
     -  
     (14,087) 
     (14,087)
  
    Stock-based compensation 
     -  
     -  
     186  
     -  
     186 
  
    Issuance of common stock related to short-term loans 
     74,477  
     -  
     334  
     -  
     334 
  
    Balances at September 30, 2023 
     34,087,201  
    $-  
    $103,975  
    $(179,199) 
    $(75,224)

For
the Nine Months Ended September 30, 2024

    Common  
    Additional Paid-In  
    Accumulated  
    Total Stockholders’ 

    Shares  
    Amount  
    Capital  
    Deficit  
    Deficit 
  
    Balances at December